ArticleBioMed research international2017

Favorable Outcomes of Chinese HCV-Related Cirrhotic Patients with Sustained Virological Response after Pegylated Interferon Plus Ribavirin Treatment.

Geng-Lin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.